Skip to main content
9860 search results for:

Myelodysplastic Syndrome 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-05-2024 | Filgrastim | News

    G-CSF-related myelodysplastic syndrome and acute myeloid leukemia

  2. 15-03-2024 | Myelodysplastic Syndrome | OriginalPaper

    A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variant

    Bloom syndrome (BS) is an autosomal recessive genetic disorder caused by variants in the BLM gene. BS is characterized by distinct facial features, elongated limbs, and various dermatological complications including photosensitivity, poikiloderma …

  3. 30-03-2024 | Myelodysplastic Syndrome | Letter

    Faggot cells observed in a patient with myelodysplastic syndrome with increased blasts

  4. 18-04-2024 | Myelodysplastic Syndrome | Online First

    Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities

    Myelodysplastic syndromes/neoplasms (MDS) comprise a group of heterogenous pathologically distinct diseases with varied prognosis and natural risk of leukemia progression [ 1 , 2 ]. MDS pathogenesis begins from different genetic alterations …

  5. Open Access 01-12-2024 | Myelodysplastic Syndrome | OriginalPaper

    The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome

    Therapy-related myelodysplastic syndrome (t-MDS) is defined as a complication in patients with cancer following exposure to chemotherapy and/or radiotherapy and has an inferior outcome compared with de novo myelodysplastic syndrome (de novo MDS).

  6. 08-12-2023 | Myelodysplastic Syndrome | Letter

    Weakening of A Antigen in Myelodysplastic Syndrome-Mimicking a Case of Wrong Blood in Tube

  7. 25-04-2024 | Myelodysplastic Syndrome | Online First

    Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia

    Myelodysplastic syndrome (MDS) is well known to be complicated by systemic inflammatory autoimmune disease (SIADs). However, it remains unclear how the prognosis after allogenic hematopoietic stem cell transplantation (allo-HSCT) in patients with …

  8. Open Access 01-12-2024 | Myelodysplastic Syndrome | OriginalPaper

    Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation

    Myelodysplastic syndrome (MDS) is characterized by a heterogeneous hematological malignancy with a wide spectrum of presentation and implications. MDS with myelofibrosis (MF) accounts for 10%–20% of patients with de novo MDS [ 1 , 2 ]. A series of …

  9. 25-03-2024 | Myelodysplastic Syndrome | Online First

    Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome

    Allogenic hematopoietic stem cell transplantation (allo-HSCT) is not a standard therapy for solid cancer because of its high toxicity and insufficient evidence levels. However, the potential graft-versus-solid-tumor (GVT) effect of this therapy …

  10. 29-03-2024 | Myelodysplastic Syndrome | EditorialNotes

    PMDA regulatory update on approval of new drugs and revisions of precautions; approval of talazoparib tosilate for prostate and breast cancer, and luspatercept for myelodysplastic syndrome in Japan

  11. Open Access 01-12-2024 | Acute Myeloid Leukemia | ReviewPaper

    Vaccines: a promising therapy for myelodysplastic syndrome

    Myelodysplastic neoplasms (MDS) define clonal hematopoietic malignancies characterized by heterogeneous mutational and clinical spectra typically seen in the elderly. Curative treatment entails allogeneic hematopoietic stem cell transplant, which …

  12. 06-02-2024 | OriginalPaper

    Decitabine-containing conditioning improved outcomes for children with higher-risk myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation

    Myelodysplastic syndrome (MDS) is a rare clonal hematopoietic disorder in children. The risk stratification system and treatment strategy for adults are unfit for children. The role of hypomethylating agents (HMAs) in higher-risk childhood MDS has …

  13. 28-09-2023 | Myelodysplastic Syndrome | OriginalPaper

    Myelodysplastic syndromes mortality in Spain: a comprehensive age-period-cohort and joinpoint analysis

    Myelodysplastic syndromes (MDS), which have recently been renamed "myelodysplastic neoplasms" by the World Health Organisation (WHO)[ 1 ], refer to a broad spectrum of hematopoietic stem cell diseases characterised by dysplasia of the myeloid cell …

  14. 22-01-2024 | Myelodysplastic Syndrome | OriginalPaper

    Pretransplant hepatomegaly is linked to relapse in patients with leukemia and myelodysplastic syndrome not in remission

    Hepatomegaly is an extramedullary disease (EMD) manifestation of hematological malignancy. Although EMD before allogeneic hematopoietic stem cell transplantation (allo-HCT) is a risk factor for relapse in patients not in complete remission (NonCR) …

  15. Open Access 01-12-2024 | Myelodysplastic Syndrome | OriginalPaper

    The role of genetic factors in pediatric myelodysplastic syndromes with different outcomes

    Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic disorders characterized by peripheral cytopenia, ineffective hematopoiesis, morphologic dysplasia, and an increased risk of progression into acute myeloid leukemia …

  16. Open Access 01-02-2024 | OriginalPaper

    The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus

    Myelodysplastic syndromes (MDS) are a group of clonal and heterogeneous diseases originating from hematopoietic stem cells, characterized by ineffective and dysplastic hematopoiesis, that have an increased risk of acute myeloid leukemia (AML) …

  17. Open Access 01-12-2024 | Myelodysplastic Syndrome | OriginalPaper

    Sequential gene expression analysis of myelodysplastic syndrome transformation identifies HOXB3 and HOXB7 as the novel targets for mesenchymal cells in disease

    MDS is a group of clonal disorders characterized by morphologic dysplasia, ineffective hematopoiesis, and peripheral cytopenia [ 1 ], with a high risk of developing acute myeloid leukemia (AML) [ 2 , 3 ]. The incidence rate of MDS in the general …

  18. 14-02-2024 | Myelodysplastic Syndrome | Online First

    Ischemic stroke as the initial presentation in acute myeloid leukemia vs. myelodysplastic syndrome: a case report and literature review with pathophysiological and clinical exploration

    Myelodysplastic syndrome (MDS) represents a heterogeneous group of clonal hematopoietic disorders, which is characterized by cytopenias in the peripheral blood and bone marrow dysplasia due to ineffective hematopoiesis. Patients with MDS have an …

  19. 24-11-2023 | Acute Myeloid Leukemia | ReviewPaper

    Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Hematologic malignancies such as acute myeloid leukemia (AML) and myelocytic dysplastic syndrome (MDS) are complex and heterogeneous diseases that present significant challenges to oncologists and researchers [ 1 – 3 ]. These diseases involve …

  20. Open Access 07-12-2023 | Myelodysplastic Syndrome | OriginalPaper

    Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK

    Myelodysplastic syndromes (MDS) are a heterogeneous group of haematopoietic diseases associated with impaired bone marrow function, persistent cytopenia and a risk of progression to acute myeloid leukaemia (AML) [ 1 ]. Higher-risk patients are …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.